应激激活激酶丝裂原活化蛋白激酶激酶7调控心脏复极的表观遗传学以预防心律失常
该研究在小鼠模型及人诱导多能干细胞来源心肌细胞中揭示丝裂原活化蛋白激酶激酶7(MKK7)缺陷通过Krüppel样因子4/组蛋白去乙酰化酶2/filamin-A复合物抑制钾通道基因转录,导致复极延迟和室性心律失常;组蛋白去乙酰化酶2抑制剂丙戊酸可恢复钾通道表达并减轻室性心律失常。
要点
- 肥厚应激下调MKK7表达与磷酸化,导致复极延迟和室性心律失常。
- MKK7缺陷使HDAC2去磷酸化并与filamin-A、KLF4形成核内复合物。
- 丙戊酸靶向该复合物恢复钾通道表达并减轻病理性重构心脏的室性心律失常。
核心结论
- 研究发现MKK7缺陷通过KLF4/HDAC2/filamin-A复合物抑制钾通道基因转录导致复极延迟和室性心律失常,支持将抗癫痫药丙戊酸重新定位为抗心律失常药。
研究设计与样本
- 使用MKK7敲除或过表达的小鼠模型研究MKK7缺陷与肥厚及衰竭心脏心律失常易感性的关系。
- 在人诱导多能干细胞来源心肌细胞中评估该致心律失常机制的人类相关性。
- 在小鼠模型和人诱导多能干细胞来源心肌细胞中探索靶向该机制的治疗潜力。
主要发现
- 肥厚应激减弱MKK7的表达和磷酸化。
- MKK7缺陷使HDAC2保持去磷酸化状态,filamin-A在核内积聚并与KLF4形成复合物。
- 该复合物导致KLF4从多个关键钾通道基因(Kv4.2、KChIP2、Kv1.5、ERG1和Kir6.2)的启动子区域解离,并降低其转录水平。
- 随之发生的复极延迟导致室性心律失常。
- 使用HDAC2抑制剂丙戊酸靶向KLF4/HDAC2/filamin-A复合物的抑制功能,可恢复K+通道表达并减轻病理性重构心脏的室性心律失常。
临床怎么用
- 作者认为该新基因调控通路可作为新的抗心律失常靶点,支持将抗癫痫药丙戊酸重新定位为抗心律失常药。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ventricular arrhythmia is a leading cause of cardiac mortality. Most antiarrhythmics present paradoxical proarrhythmic side effects, culminating in a greater risk of sudden death. METHODS: We describe a new regulatory mechanism linking mitogen-activated kinase kinase-7 deficiency with increased arrhythmia vulnerability in hypertrophied and failing hearts using mouse models harboring mitogen-activated kinase kinase-7 knockout or overexpression. The human relevance of this arrhythmogenic mechanism is evaluated in human-induced pluripotent stem cell-derived cardiomyocytes. Therapeutic potentials by targeting this mechanism are explored in the mouse models and human-induced pluripotent stem cell-derived cardiomyocytes. RESULTS: Mechanistically, hypertrophic stress dampens expression and phosphorylation of mitogen-activated kinase kinase-7. Such mitogen-activated kinase kinase-7 deficiency leaves histone deacetylase-2 unphosphorylated and filamin-A accumulated in the nucleus to form a complex with Krüppel-like factor-4. This complex leads to Krüppel-like factor-4 disassociation from the promoter regions of multiple key potassium channel genes (Kv4.2, KChIP2, Kv1.5, ERG1, and Kir6.2) and reduction of their transcript levels. Consequent repolarization delays result in ventricular arrhythmias. Therapeutically, targeting the repressive function of the Krüppel-like factor-4/histone deacetylase-2/filamin-A complex with the histone deacetylase-2 inhibitor valproic acid restores K+ channel expression and alleviates ventricular arrhythmias in pathologically remodeled hearts. CONCLUSIONS: Our findings unveil this new gene regulatory avenue as a new antiarrhythmic target where repurposing of the antiepileptic drug valproic acid as an antiarrhythmic is supported.
引用
- Chowdhury SK, Liu W, Zi M, et al. Stress-Activated Kinase Mitogen-Activated Kinase Kinase-7 Governs Epigenetics of Cardiac Repolarization for Arrhythmia Prevention. Circulation. 2016. PMID: 27899394. doi:10.1161/CIRCULATIONAHA.116.022941
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。